We have a patented technology for the synthesis of bio-aromatics from agricultural waste. Our goal is to replace phenolic bases for adhesives, coatings, surfactants, foams and more, for applications.
The key goal of CureDiab is the development of novel GABA-A receptor modulators as a first-in-class therapy of fatty liver disease.
The unique platform that combines Healthcare technologies with Orphan Disease treatments based on Cannabinoids.
ScobyTec’s platform technology is the solution for the future need for new materials like leather replacement, technical papers and lightweight construction materials, made with biofabrication and in a sustainable process throughout the entire production line.